AI Science Tracker
EN

Department of Otolaryngology Head and Neck Surgery

1 discovery from 2023

Discoveries

Clustering and machine learning-based integration identify cancer associated fibroblasts genes' signature in head and neck squamous cell carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Clustering and ML identify a cancer-associated fibroblast signature in head-and-neck cancer, with associations to prognosis, immunosuppression, HPV status and ligand-receptor signaling. This is a specific tumor-microenvironment result from transcriptomic/single-cell analyses; mechanisms remain associative.

Technology: Original Methods examined; model operation and its relationship to the stated result are described in the source.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Original Methods examined; model operation and its relationship to the stated result are described in the source.
Limitation / still unknown
Original Methods/Results identify the datasets, assays or cohort comparison supporting the claim.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/fgene/articles/10.3389/fgene.2023.1111816/full · https://pubmed.ncbi.nlm.nih.gov/37065499/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.